US Bancorp

US Bancorp’s Keros Therapeutics KROS Stock Holding History

US Bancorp’s Portfolio KROS Stock Details KROS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$386	Sell	35 -499	-93%	-$7.71K	﹤0.01%	4027
2025 Q4	$10.9K	Hold	534	–	–	﹤0.01%	3307
2025 Q3	$8.45K	Sell	534 -9,330	-95%	-$138K	﹤0.01%	3369
2025 Q2	$132K	Buy	9,864 +9,848	+61,550%	+$133K	﹤0.01%	2287
2025 Q1	$163	Sell	16 -174	-92%	-$2.02K	﹤0.01%	4101
2024 Q4	$3.01K	Sell	190 -57	-23%	-$2.96K	﹤0.01%	3768
2024 Q3	$14.3K	Sell	247 -38	-13%	-$1.88K	﹤0.01%	3234
2024 Q2	$13K	Sell	285 -110	-28%	-$5.91K	﹤0.01%	3220
2024 Q1	$26.1K	Buy	395 +48	+14%	+$2.85K	﹤0.01%	2984
2023 Q4	$13.8K	Buy	+347	New	+$10.9K	﹤0.01%	3201
2023 Q3	–	Sell	-55	Closed	-$2.21K	–	4064
2023 Q2	$2.21K	Hold	55	–	–	﹤0.01%	3665
2023 Q1	$2.35K	Hold	55	–	–	﹤0.01%	3720
2022 Q4	$2.64K	Hold	55	–	–	﹤0.01%	3703
2022 Q3	$2K	Buy	55 +14	+34%	+$485	﹤0.01%	3836
2022 Q2	$1K	Hold	41	–	–	﹤0.01%	3967
2022 Q1	$2K	Hold	41	–	–	﹤0.01%	3838
2021 Q4	$2K	Hold	41	–	–	﹤0.01%	3895
2021 Q3	$2K	Buy	+41	New	+$1.46K	﹤0.01%	3890

Other funds holding KROS

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return

Jacobs Levy Equity Management

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return